Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Robert

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
Neoplasia (New York, N.Y.)|March 13, 2013
Anti-HER3 domain 1 and 3 antibodies reduce tumor growth by hindering HER2/HER3 dimerization and AKT-induced MDM2, XIAP, and FoxO1 phosphorylationYassamine Lazrek, Olivier Dubreuil, Véronique Garambois, et al.
Oncotarget|September 13, 2014
HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical modelsGaëlle Thomas, Thierry Chardès, Nadège Gaborit, et al.
Cancer Letters|June 24, 2018
Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancerCharline Ogier, Pierre-Emmanuel Colombo, Corinne Bousquet, et al.
Biophysical Journal|August 17, 2011
Molecular adaptation of photoprotection: triplet states in light-harvesting proteinsAndrew Gall, Rudi Berera, Maxime T A Alexandre, et al.
Theranostics|August 8, 2018
Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumorsDiego Sanchez-Martinez, Nerea Allende-Vega, Stefania Orecchioni, et al.
EMBO Molecular Medicine|February 14, 2018
Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancerMaya Jeitany, Cédric Leroy, Priscillia Tosti, et al.
Nature Medicine|March 25, 2014
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNAAlain R Thierry, Florent Mouliere, Safia El Messaoudi, et al.
Chemical Science|October 17, 2024
Perylene-derivative singlet exciton fission in water solutionChloe Magne, Simona Streckaite, Roberto A Boto, et al.
Chemical Science|December 6, 2024
Correction: Perylene-derivative singlet exciton fission in water solutionChloe Magne, Simona Streckaite, Roberto A Boto, et al.
Mabs|May 15, 2023
10th antibody industrial symposium: new developments in antibody and adoptive cell therapiesAna Antunes, Luis Alvarez-Vallina, Federico Bertoglio, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Neoplasia (New York, N.Y.)|March 13, 2013
Anti-HER3 domain 1 and 3 antibodies reduce tumor growth by hindering HER2/HER3 dimerization and AKT-induced MDM2, XIAP, and FoxO1 phosphorylationYassamine Lazrek, Olivier Dubreuil, Véronique Garambois, et al.
Oncotarget|September 13, 2014
HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical modelsGaëlle Thomas, Thierry Chardès, Nadège Gaborit, et al.
Cancer Letters|June 24, 2018
Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancerCharline Ogier, Pierre-Emmanuel Colombo, Corinne Bousquet, et al.
Biophysical Journal|August 17, 2011
Molecular adaptation of photoprotection: triplet states in light-harvesting proteinsAndrew Gall, Rudi Berera, Maxime T A Alexandre, et al.
Theranostics|August 8, 2018
Expansion of allogeneic NK cells with efficient antibody-dependent cell cytotoxicity against multiple tumorsDiego Sanchez-Martinez, Nerea Allende-Vega, Stefania Orecchioni, et al.
EMBO Molecular Medicine|February 14, 2018
Inhibition of DDR1-BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancerMaya Jeitany, Cédric Leroy, Priscillia Tosti, et al.
Nature Medicine|March 25, 2014
Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNAAlain R Thierry, Florent Mouliere, Safia El Messaoudi, et al.
Chemical Science|October 17, 2024
Perylene-derivative singlet exciton fission in water solutionChloe Magne, Simona Streckaite, Roberto A Boto, et al.
Chemical Science|December 6, 2024
Correction: Perylene-derivative singlet exciton fission in water solutionChloe Magne, Simona Streckaite, Roberto A Boto, et al.
Mabs|May 15, 2023
10th antibody industrial symposium: new developments in antibody and adoptive cell therapiesAna Antunes, Luis Alvarez-Vallina, Federico Bertoglio, et al.
Pageof 18